Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Oral Contrast Agent Market Growth 2022-2028

  • LP 4923150
  • 101 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Oral Contrast Agent will have significant change from previous year. According to our (LP Information) latest study, the global Oral Contrast Agent market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Oral Contrast Agent market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Oral Contrast Agent market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oral Contrast Agent market, reaching US$ million by the year 2028. As for the Europe Oral Contrast Agent landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Oral Contrast Agent players cover GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), and Guerbet (France), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Contrast Agent market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Barium-based Contrast Media

Iodinated Contrast Media

Gadolinium-based Contrast Media

Microbubble Contrast Media

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Cardiovascular Disorders

Cancer

Gastrointestinal Disorders

Musculoskeletal Disorders

Neurological Disorders

Nephrological Disorders

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

GE Healthcare (US)

Bracco Imaging (Italy)

Bayer HealthCare (Germany)

Guerbet (France)

Lantheus (US)

Daiichi Sankyo (Japan)

Unijules Life Sciences (India)

J.B. Chemicals and Pharmaceuticals (India)

Spago Nanomedicine (Sweden)

Taejoon Pharm (South Korea)

Jodas (India)

Magnus Health (India)

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Oral Contrast Agent Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Oral Contrast Agent by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Oral Contrast Agent by Country/Region, 2017, 2022 & 2028

2.2 Oral Contrast Agent Segment by Type

2.2.1 Barium-based Contrast Media

2.2.2 Iodinated Contrast Media

2.2.3 Gadolinium-based Contrast Media

2.2.4 Microbubble Contrast Media

2.3 Oral Contrast Agent Sales by Type

2.3.1 Global Oral Contrast Agent Sales Market Share by Type (2017-2022)

2.3.2 Global Oral Contrast Agent Revenue and Market Share by Type (2017-2022)

2.3.3 Global Oral Contrast Agent Sale Price by Type (2017-2022)

2.4 Oral Contrast Agent Segment by Application

2.4.1 Cardiovascular Disorders

2.4.2 Cancer

2.4.3 Gastrointestinal Disorders

2.4.4 Musculoskeletal Disorders

2.4.5 Neurological Disorders

2.4.6 Nephrological Disorders

2.5 Oral Contrast Agent Sales by Application

2.5.1 Global Oral Contrast Agent Sale Market Share by Application (2017-2022)

2.5.2 Global Oral Contrast Agent Revenue and Market Share by Application (2017-2022)

2.5.3 Global Oral Contrast Agent Sale Price by Application (2017-2022)

3 Global Oral Contrast Agent by Company

3.1 Global Oral Contrast Agent Breakdown Data by Company

3.1.1 Global Oral Contrast Agent Annual Sales by Company (2020-2022)

3.1.2 Global Oral Contrast Agent Sales Market Share by Company (2020-2022)

3.2 Global Oral Contrast Agent Annual Revenue by Company (2020-2022)

3.2.1 Global Oral Contrast Agent Revenue by Company (2020-2022)

3.2.2 Global Oral Contrast Agent Revenue Market Share by Company (2020-2022)

3.3 Global Oral Contrast Agent Sale Price by Company

3.4 Key Manufacturers Oral Contrast Agent Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Oral Contrast Agent Product Location Distribution

3.4.2 Players Oral Contrast Agent Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Oral Contrast Agent by Geographic Region

4.1 World Historic Oral Contrast Agent Market Size by Geographic Region (2017-2022)

4.1.1 Global Oral Contrast Agent Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Oral Contrast Agent Annual Revenue by Geographic Region

4.2 World Historic Oral Contrast Agent Market Size by Country/Region (2017-2022)

4.2.1 Global Oral Contrast Agent Annual Sales by Country/Region (2017-2022)

4.2.2 Global Oral Contrast Agent Annual Revenue by Country/Region

4.3 Americas Oral Contrast Agent Sales Growth

4.4 APAC Oral Contrast Agent Sales Growth

4.5 Europe Oral Contrast Agent Sales Growth

4.6 Middle East & Africa Oral Contrast Agent Sales Growth

5 Americas

5.1 Americas Oral Contrast Agent Sales by Country

5.1.1 Americas Oral Contrast Agent Sales by Country (2017-2022)

5.1.2 Americas Oral Contrast Agent Revenue by Country (2017-2022)

5.2 Americas Oral Contrast Agent Sales by Type

5.3 Americas Oral Contrast Agent Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Oral Contrast Agent Sales by Region

6.1.1 APAC Oral Contrast Agent Sales by Region (2017-2022)

6.1.2 APAC Oral Contrast Agent Revenue by Region (2017-2022)

6.2 APAC Oral Contrast Agent Sales by Type

6.3 APAC Oral Contrast Agent Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Oral Contrast Agent by Country

7.1.1 Europe Oral Contrast Agent Sales by Country (2017-2022)

7.1.2 Europe Oral Contrast Agent Revenue by Country (2017-2022)

7.2 Europe Oral Contrast Agent Sales by Type

7.3 Europe Oral Contrast Agent Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Oral Contrast Agent by Country

8.1.1 Middle East & Africa Oral Contrast Agent Sales by Country (2017-2022)

8.1.2 Middle East & Africa Oral Contrast Agent Revenue by Country (2017-2022)

8.2 Middle East & Africa Oral Contrast Agent Sales by Type

8.3 Middle East & Africa Oral Contrast Agent Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Oral Contrast Agent

10.3 Manufacturing Process Analysis of Oral Contrast Agent

10.4 Industry Chain Structure of Oral Contrast Agent

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Oral Contrast Agent Distributors

11.3 Oral Contrast Agent Customer

12 World Forecast Review for Oral Contrast Agent by Geographic Region

12.1 Global Oral Contrast Agent Market Size Forecast by Region

12.1.1 Global Oral Contrast Agent Forecast by Region (2023-2028)

12.1.2 Global Oral Contrast Agent Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Oral Contrast Agent Forecast by Type

12.7 Global Oral Contrast Agent Forecast by Application

13 Key Players Analysis

13.1 GE Healthcare (US)

13.1.1 GE Healthcare (US) Company Information

13.1.2 GE Healthcare (US) Oral Contrast Agent Product Offered

13.1.3 GE Healthcare (US) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GE Healthcare (US) Main Business Overview

13.1.5 GE Healthcare (US) Latest Developments

13.2 Bracco Imaging (Italy)

13.2.1 Bracco Imaging (Italy) Company Information

13.2.2 Bracco Imaging (Italy) Oral Contrast Agent Product Offered

13.2.3 Bracco Imaging (Italy) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bracco Imaging (Italy) Main Business Overview

13.2.5 Bracco Imaging (Italy) Latest Developments

13.3 Bayer HealthCare (Germany)

13.3.1 Bayer HealthCare (Germany) Company Information

13.3.2 Bayer HealthCare (Germany) Oral Contrast Agent Product Offered

13.3.3 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bayer HealthCare (Germany) Main Business Overview

13.3.5 Bayer HealthCare (Germany) Latest Developments

13.4 Guerbet (France)

13.4.1 Guerbet (France) Company Information

13.4.2 Guerbet (France) Oral Contrast Agent Product Offered

13.4.3 Guerbet (France) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Guerbet (France) Main Business Overview

13.4.5 Guerbet (France) Latest Developments

13.5 Lantheus (US)

13.5.1 Lantheus (US) Company Information

13.5.2 Lantheus (US) Oral Contrast Agent Product Offered

13.5.3 Lantheus (US) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Lantheus (US) Main Business Overview

13.5.5 Lantheus (US) Latest Developments

13.6 Daiichi Sankyo (Japan)

13.6.1 Daiichi Sankyo (Japan) Company Information

13.6.2 Daiichi Sankyo (Japan) Oral Contrast Agent Product Offered

13.6.3 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Daiichi Sankyo (Japan) Main Business Overview

13.6.5 Daiichi Sankyo (Japan) Latest Developments

13.7 Unijules Life Sciences (India)

13.7.1 Unijules Life Sciences (India) Company Information

13.7.2 Unijules Life Sciences (India) Oral Contrast Agent Product Offered

13.7.3 Unijules Life Sciences (India) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Unijules Life Sciences (India) Main Business Overview

13.7.5 Unijules Life Sciences (India) Latest Developments

13.8 J.B. Chemicals and Pharmaceuticals (India)

13.8.1 J.B. Chemicals and Pharmaceuticals (India) Company Information

13.8.2 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Offered

13.8.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 J.B. Chemicals and Pharmaceuticals (India) Main Business Overview

13.8.5 J.B. Chemicals and Pharmaceuticals (India) Latest Developments

13.9 Spago Nanomedicine (Sweden)

13.9.1 Spago Nanomedicine (Sweden) Company Information

13.9.2 Spago Nanomedicine (Sweden) Oral Contrast Agent Product Offered

13.9.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Spago Nanomedicine (Sweden) Main Business Overview

13.9.5 Spago Nanomedicine (Sweden) Latest Developments

13.10 Taejoon Pharm (South Korea)

13.10.1 Taejoon Pharm (South Korea) Company Information

13.10.2 Taejoon Pharm (South Korea) Oral Contrast Agent Product Offered

13.10.3 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Taejoon Pharm (South Korea) Main Business Overview

13.10.5 Taejoon Pharm (South Korea) Latest Developments

13.11 Jodas (India)

13.11.1 Jodas (India) Company Information

13.11.2 Jodas (India) Oral Contrast Agent Product Offered

13.11.3 Jodas (India) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Jodas (India) Main Business Overview

13.11.5 Jodas (India) Latest Developments

13.12 Magnus Health (India)

13.12.1 Magnus Health (India) Company Information

13.12.2 Magnus Health (India) Oral Contrast Agent Product Offered

13.12.3 Magnus Health (India) Oral Contrast Agent Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Magnus Health (India) Main Business Overview

13.12.5 Magnus Health (India) Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Oral Contrast Agent Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Oral Contrast Agent Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Barium-based Contrast Media

Table 4. Major Players of Iodinated Contrast Media

Table 5. Major Players of Gadolinium-based Contrast Media

Table 6. Major Players of Microbubble Contrast Media

Table 7. Global Oral Contrast Agent Sales by Type (2017-2022) & (K Pcs)

Table 8. Global Oral Contrast Agent Sales Market Share by Type (2017-2022)

Table 9. Global Oral Contrast Agent Revenue by Type (2017-2022) & ($ million)

Table 10. Global Oral Contrast Agent Revenue Market Share by Type (2017-2022)

Table 11. Global Oral Contrast Agent Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global Oral Contrast Agent Sales by Application (2017-2022) & (K Pcs)

Table 13. Global Oral Contrast Agent Sales Market Share by Application (2017-2022)

Table 14. Global Oral Contrast Agent Revenue by Application (2017-2022)

Table 15. Global Oral Contrast Agent Revenue Market Share by Application (2017-2022)

Table 16. Global Oral Contrast Agent Sale Price by Application (2017-2022) & (USD/Pcs)

Table 17. Global Oral Contrast Agent Sales by Company (2020-2022) & (K Pcs)

Table 18. Global Oral Contrast Agent Sales Market Share by Company (2020-2022)

Table 19. Global Oral Contrast Agent Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Oral Contrast Agent Revenue Market Share by Company (2020-2022)

Table 21. Global Oral Contrast Agent Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers Oral Contrast Agent Producing Area Distribution and Sales Area

Table 23. Players Oral Contrast Agent Products Offered

Table 24. Oral Contrast Agent Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Oral Contrast Agent Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global Oral Contrast Agent Sales Market Share Geographic Region (2017-2022)

Table 29. Global Oral Contrast Agent Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Oral Contrast Agent Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Oral Contrast Agent Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global Oral Contrast Agent Sales Market Share by Country/Region (2017-2022)

Table 33. Global Oral Contrast Agent Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Oral Contrast Agent Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Oral Contrast Agent Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas Oral Contrast Agent Sales Market Share by Country (2017-2022)

Table 37. Americas Oral Contrast Agent Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Oral Contrast Agent Revenue Market Share by Country (2017-2022)

Table 39. Americas Oral Contrast Agent Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas Oral Contrast Agent Sales Market Share by Type (2017-2022)

Table 41. Americas Oral Contrast Agent Sales by Application (2017-2022) & (K Pcs)

Table 42. Americas Oral Contrast Agent Sales Market Share by Application (2017-2022)

Table 43. APAC Oral Contrast Agent Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC Oral Contrast Agent Sales Market Share by Region (2017-2022)

Table 45. APAC Oral Contrast Agent Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Oral Contrast Agent Revenue Market Share by Region (2017-2022)

Table 47. APAC Oral Contrast Agent Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC Oral Contrast Agent Sales Market Share by Type (2017-2022)

Table 49. APAC Oral Contrast Agent Sales by Application (2017-2022) & (K Pcs)

Table 50. APAC Oral Contrast Agent Sales Market Share by Application (2017-2022)

Table 51. Europe Oral Contrast Agent Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe Oral Contrast Agent Sales Market Share by Country (2017-2022)

Table 53. Europe Oral Contrast Agent Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Oral Contrast Agent Revenue Market Share by Country (2017-2022)

Table 55. Europe Oral Contrast Agent Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe Oral Contrast Agent Sales Market Share by Type (2017-2022)

Table 57. Europe Oral Contrast Agent Sales by Application (2017-2022) & (K Pcs)

Table 58. Europe Oral Contrast Agent Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Oral Contrast Agent Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa Oral Contrast Agent Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Oral Contrast Agent Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Oral Contrast Agent Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Oral Contrast Agent Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Oral Contrast Agent Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Oral Contrast Agent Sales by Application (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Oral Contrast Agent Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Oral Contrast Agent

Table 68. Key Market Challenges & Risks of Oral Contrast Agent

Table 69. Key Industry Trends of Oral Contrast Agent

Table 70. Oral Contrast Agent Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Oral Contrast Agent Distributors List

Table 73. Oral Contrast Agent Customer List

Table 74. Global Oral Contrast Agent Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global Oral Contrast Agent Sales Market Forecast by Region

Table 76. Global Oral Contrast Agent Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Oral Contrast Agent Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Oral Contrast Agent Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas Oral Contrast Agent Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Oral Contrast Agent Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC Oral Contrast Agent Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Oral Contrast Agent Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe Oral Contrast Agent Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Oral Contrast Agent Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa Oral Contrast Agent Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Oral Contrast Agent Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global Oral Contrast Agent Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Oral Contrast Agent Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Oral Contrast Agent Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Oral Contrast Agent Sales Forecast by Application (2023-2028) & (K Pcs)

Table 91. Global Oral Contrast Agent Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Oral Contrast Agent Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Oral Contrast Agent Revenue Market Share Forecast by Application (2023-2028)

Table 94. GE Healthcare (US) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors

Table 95. GE Healthcare (US) Oral Contrast Agent Product Offered

Table 96. GE Healthcare (US) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. GE Healthcare (US) Main Business

Table 98. GE Healthcare (US) Latest Developments

Table 99. Bracco Imaging (Italy) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors

Table 100. Bracco Imaging (Italy) Oral Contrast Agent Product Offered

Table 101. Bracco Imaging (Italy) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. Bracco Imaging (Italy) Main Business

Table 103. Bracco Imaging (Italy) Latest Developments

Table 104. Bayer HealthCare (Germany) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors

Table 105. Bayer HealthCare (Germany) Oral Contrast Agent Product Offered

Table 106. Bayer HealthCare (Germany) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 107. Bayer HealthCare (Germany) Main Business

Table 108. Bayer HealthCare (Germany) Latest Developments

Table 109. Guerbet (France) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors

Table 110. Guerbet (France) Oral Contrast Agent Product Offered

Table 111. Guerbet (France) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 112. Guerbet (France) Main Business

Table 113. Guerbet (France) Latest Developments

Table 114. Lantheus (US) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors

Table 115. Lantheus (US) Oral Contrast Agent Product Offered

Table 116. Lantheus (US) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 117. Lantheus (US) Main Business

Table 118. Lantheus (US) Latest Developments

Table 119. Daiichi Sankyo (Japan) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors

Table 120. Daiichi Sankyo (Japan) Oral Contrast Agent Product Offered

Table 121. Daiichi Sankyo (Japan) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 122. Daiichi Sankyo (Japan) Main Business

Table 123. Daiichi Sankyo (Japan) Latest Developments

Table 124. Unijules Life Sciences (India) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors

Table 125. Unijules Life Sciences (India) Oral Contrast Agent Product Offered

Table 126. Unijules Life Sciences (India) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 127. Unijules Life Sciences (India) Main Business

Table 128. Unijules Life Sciences (India) Latest Developments

Table 129. J.B. Chemicals and Pharmaceuticals (India) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors

Table 130. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Offered

Table 131. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 132. J.B. Chemicals and Pharmaceuticals (India) Main Business

Table 133. J.B. Chemicals and Pharmaceuticals (India) Latest Developments

Table 134. Spago Nanomedicine (Sweden) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors

Table 135. Spago Nanomedicine (Sweden) Oral Contrast Agent Product Offered

Table 136. Spago Nanomedicine (Sweden) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 137. Spago Nanomedicine (Sweden) Main Business

Table 138. Spago Nanomedicine (Sweden) Latest Developments

Table 139. Taejoon Pharm (South Korea) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors

Table 140. Taejoon Pharm (South Korea) Oral Contrast Agent Product Offered

Table 141. Taejoon Pharm (South Korea) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 142. Taejoon Pharm (South Korea) Main Business

Table 143. Taejoon Pharm (South Korea) Latest Developments

Table 144. Jodas (India) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors

Table 145. Jodas (India) Oral Contrast Agent Product Offered

Table 146. Jodas (India) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 147. Jodas (India) Main Business

Table 148. Jodas (India) Latest Developments

Table 149. Magnus Health (India) Basic Information, Oral Contrast Agent Manufacturing Base, Sales Area and Its Competitors

Table 150. Magnus Health (India) Oral Contrast Agent Product Offered

Table 151. Magnus Health (India) Oral Contrast Agent Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 152. Magnus Health (India) Main Business

Table 153. Magnus Health (India) Latest Developments

List of Figures

Figure 1. Picture of Oral Contrast Agent

Figure 2. Oral Contrast Agent Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Oral Contrast Agent Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Oral Contrast Agent Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Oral Contrast Agent Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Barium-based Contrast Media

Figure 10. Product Picture of Iodinated Contrast Media

Figure 11. Product Picture of Gadolinium-based Contrast Media

Figure 12. Product Picture of Microbubble Contrast Media

Figure 13. Global Oral Contrast Agent Sales Market Share by Type in 2021

Figure 14. Global Oral Contrast Agent Revenue Market Share by Type (2017-2022)

Figure 15. Oral Contrast Agent Consumed in Cardiovascular Disorders

Figure 16. Global Oral Contrast Agent Market: Cardiovascular Disorders (2017-2022) & (K Pcs)

Figure 17. Oral Contrast Agent Consumed in Cancer

Figure 18. Global Oral Contrast Agent Market: Cancer (2017-2022) & (K Pcs)

Figure 19. Oral Contrast Agent Consumed in Gastrointestinal Disorders

Figure 20. Global Oral Contrast Agent Market: Gastrointestinal Disorders (2017-2022) & (K Pcs)

Figure 21. Oral Contrast Agent Consumed in Musculoskeletal Disorders

Figure 22. Global Oral Contrast Agent Market: Musculoskeletal Disorders (2017-2022) & (K Pcs)

Figure 23. Oral Contrast Agent Consumed in Neurological Disorders

Figure 24. Global Oral Contrast Agent Market: Neurological Disorders (2017-2022) & (K Pcs)

Figure 25. Oral Contrast Agent Consumed in Nephrological Disorders

Figure 26. Global Oral Contrast Agent Market: Nephrological Disorders (2017-2022) & (K Pcs)

Figure 27. Global Oral Contrast Agent Sales Market Share by Application (2017-2022)

Figure 28. Global Oral Contrast Agent Revenue Market Share by Application in 2021

Figure 29. Oral Contrast Agent Revenue Market by Company in 2021 ($ Million)

Figure 30. Global Oral Contrast Agent Revenue Market Share by Company in 2021

Figure 31. Global Oral Contrast Agent Sales Market Share by Geographic Region (2017-2022)

Figure 32. Global Oral Contrast Agent Revenue Market Share by Geographic Region in 2021

Figure 33. Global Oral Contrast Agent Sales Market Share by Region (2017-2022)

Figure 34. Global Oral Contrast Agent Revenue Market Share by Country/Region in 2021

Figure 35. Americas Oral Contrast Agent Sales 2017-2022 (K Pcs)

Figure 36. Americas Oral Contrast Agent Revenue 2017-2022 ($ Millions)

Figure 37. APAC Oral Contrast Agent Sales 2017-2022 (K Pcs)

Figure 38. APAC Oral Contrast Agent Revenue 2017-2022 ($ Millions)

Figure 39. Europe Oral Contrast Agent Sales 2017-2022 (K Pcs)

Figure 40. Europe Oral Contrast Agent Revenue 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Oral Contrast Agent Sales 2017-2022 (K Pcs)

Figure 42. Middle East & Africa Oral Contrast Agent Revenue 2017-2022 ($ Millions)

Figure 43. Americas Oral Contrast Agent Sales Market Share by Country in 2021

Figure 44. Americas Oral Contrast Agent Revenue Market Share by Country in 2021

Figure 45. United States Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 46. Canada Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 47. Mexico Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 48. Brazil Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 49. APAC Oral Contrast Agent Sales Market Share by Region in 2021

Figure 50. APAC Oral Contrast Agent Revenue Market Share by Regions in 2021

Figure 51. China Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 52. Japan Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 53. South Korea Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 54. Southeast Asia Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 55. India Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 56. Australia Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 57. Europe Oral Contrast Agent Sales Market Share by Country in 2021

Figure 58. Europe Oral Contrast Agent Revenue Market Share by Country in 2021

Figure 59. Germany Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 60. France Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 61. UK Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 62. Italy Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 63. Russia Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 64. Middle East & Africa Oral Contrast Agent Sales Market Share by Country in 2021

Figure 65. Middle East & Africa Oral Contrast Agent Revenue Market Share by Country in 2021

Figure 66. Egypt Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 67. South Africa Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 68. Israel Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 69. Turkey Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 70. GCC Country Oral Contrast Agent Revenue Growth 2017-2022 ($ Millions)

Figure 71. Manufacturing Cost Structure Analysis of Oral Contrast Agent in 2021

Figure 72. Manufacturing Process Analysis of Oral Contrast Agent

Figure 73. Industry Chain Structure of Oral Contrast Agent

Figure 74. Channels of Distribution

Figure 75. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390